Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Mesothelioma 1 Medulloblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Sorafenib 29 Nivolumab 15 pembrolizumab 12 Radiosurgery 9 Bevacizumab 9 atezolizumab 7 regorafenib 5 Radiotherapy 5 Fluorouracil 5 Doxorubicin 5 lenvatinib 4 Sunitinib 4 Oxaliplatin 4 Ipilimumab 4 Gemcitabine 4 Ethiodized Oil 4 Erlotinib Hydrochloride 4 Capecitabine 4 TLC 388 3 Radiofrequency Ablation 3 Leucovorin 3 Everolimus 3 Cisplatin 3 Blood Specimen Collection 3 toripalimab 2 phosphomannopentaose sulfate 2 durvalumab 2 cediranib 2 avelumab 2 Tirapazamine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Hepatocellular × Acetylcysteine × Clear all

NCT01726465 2013-11-13

MENHIR

Istituto Clinico Humanitas

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡